All ProductsDisplaying Products by Catalog Number (5900 - 5999)
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000810082008300840085008600870088008900
| Cat. No. | Product Name / Activity |
|---|---|
| 5900 | c-Di-GMP sodium salt |
| Endogenous STING and DDX41 agonist; activates STING-dependent signaling | |
| 5901 | c-Di-AMP sodium salt |
| Endogenous STING and DDX41 agonist; activates STING-dependent signaling | |
| 5902 | Tiotropium bromide |
| Potent muscarinic receptor antagonist | |
| 5903 | CATPB |
| FFA2 (GPR43) inverse agonist | |
| 5906 | Imatinib mesylate |
| Potent and selective v-Abl tyrosine kinase inhibitor; also inhibits PDGFR and c-kit | |
| 5910 | TL4-12 |
| Potent MAP4K2 (GCK) inhibitor | |
| 5911 | FFN 200 dihydrochloride |
| Selective fluorescent VMAT2 substrate | |
| 5913 | Ro 6842262 |
| Potent LPA1 antagonist | |
| 5914 | AM 0902 |
| Potent and selective TRPA1 antagonist | |
| 5915 | PF 04449613 |
| Potent PDE9 inhibitor; brain penetrant | |
| 5916 | Canertinib dihydrochloride |
| Potent EGFR kinase inhibitor | |
| 5920 | LG 100268 |
| Potent and selective RXR agonist; also activates RXR/PPARγ heterodimers | |
| 5922 | CRT 0066854 hydrochloride |
| PKCι and PKCζ inhibitor | |
| 5931 | PF 05089771 |
| Potent and selective Nav1.7 channel blocker | |
| 5934 | NCT 501 hydrochloride |
| Potent and selective ALDH1A1 inhibitor | |
| 5935 | H2DCFDA |
| Fluorescent ROS indicator; cell permeable | |
| 5937 | A 779 |
| Selective Mas receptor (Ang-(1-7) receptor) antagonist | |
| 5941 | OD1 |
| Potent hNav1.4, rNav1.6 and rNav1.7 channel activator | |
| 5943 | ML 339 |
| Potent and selective hCXCR6 antagonist | |
| 5945 | 2',3'-cGAMP sodium salt |
| Endogenous high affinity STING agonist | |
| 5948 | DMNPE-4 AM-caged-calcium |
| Calcium cage; cell permeable | |
| 5950 | Ethyl LipotF |
| Selective FTO inhibitor | |
| 5951 | WAY 252623 |
| Potent LXR agonist | |
| 5952 | PDD 00017273 |
| Potent and selective PARG inhibitor; cell permeable | |
| 5953 | Adaptaquin |
| HIF-prolyl hydroxylase-2 (PHD2) inhibitor; antioxidant | |
| 5959 | Autocamtide-2-related inhibitory peptide, myristoylated |
| CaM kinase II inhibitor; enhanced cell permeable derivative of Autocamtide-2-related inhibitory peptide | |
| 5960 | TMI 1 |
| Adam 17 (TACE) and MMP inhibitor; orally bioavailable | |
| 5961 | HIOC |
| Selective TrkB receptor agonist; neuroprotectant | |
| 5963 | CMPI hydrochloride |
| Potent positive allosteric modulator of α4β2 nAChRs; also inhibitor of (α4)2(β2)3, muscle-type and Torpedo nAChRs | |
| 5964 | SI-2 hydrochloride |
| Steroid receptor coactivator 3 (SRC-3) inhibitor | |
| 5966 | ML 233 |
| Non-peptide apelin agonist | |
| 5970 | BAY 299 |
| Potent and selective BRD1 and TAF1 inhibitor | |
| 5981 | Itraconazole |
| SMO antagonist; acts at different binding site to cyclopamine (Cat No. 1623) | |
| 5982 | cis-6-Hydroxynorketamine hydrochloride |
| Enhances AMPA currents: antidepressant | |
| 5983 | BMS 986187 |
| Potent positive allosteric modulator of δ receptors | |
| 5985 | AKT Inhibitor IV |
| Promotes Akt hyperphosphorylation; decreases phosphorylation of Akt substrates | |
| 5986 | NAV 2729 |
| Selective ARF6 inhibitor | |
| 5987 | (±)-ML 209 |
| RORγt inverse agonist; suppresses Th17 cell differentiation | |
| 5989 | BIRB 796 |
| High affinity and selective p38 kinase inhibitor | |
| 5992 | MM 54 |
| Potent apelin antagonist | |
| 5993 | CP 673451 |
| Potent and selective PDGFR inhibitor | |
| 5995 | AMG 517 |
| Potent TRPV1 antagonist | |
| 5996 | (R)-Norketamine hydrochloride |
| NMDA receptor modulator; analgesic | |
| 5999 | TP 472N |
| Negative control for TP 472 |